Improve Research Reproducibility A Bio-protocol resource
bpdetail_icon_lock
Preprint

RNA interference

SC Shawn C. Chafe
SD Shoukat Dedhar

Last updated date: Feb 24, 2022 Views: 667 Forks: 0

original An abbreviated version of this protocol was published in Science Advances
Genome-wide synthetic lethal screen unveils novel CAIX-NFS1/xCT axis as a targetable vulnerability in hypoxic solid tumors
download pdf Download PDF
ask Ask a question
cite How to cite
nfavorite Favorite

siRNA Transfection with siLentFect (6-well)


Required reagents:

  • siLentfect (Bio-Rad #1703360)
  • siRNA to gene of interest (20 mM – Qiagen)
  • OPTI-MEM (Thermofisher Scientific #31985070)
  • 6-well plates (VWR # CA62406-161)

 

Protocol:

  1. siRNA should be 20 μM
  2. Label tubes and plates. Let reagents and OPTI get to RT before use. Vortex reagents.
  3. Add 7.5 μL siRNA and 500 μL Opti-MEM. Vortex.
  4. To another tube: add 2.5 μL siLentfect and 500 μL Opti. Vortex.
  5. Combine 3 and 4 for 20 minutes.
  6. Meanwhile, split cells so that they will be ~75% confluent at plating (Cell type dependent and requires titration to determine this value. 5x104 cells/cm2 is a good starting point).
  7. Add 1 mL of cells at desired concentration (see #6) to each well of 6-well. Add the combined siRNA mix and pipette up and down.
  8. Change media or split the next day. 
  9. Assay efficiency of gene depletion 72 hours post-transfection.
Copyright: Content may be subjected to copyright.
How to cite：
Readers should cite both the Bio-protocol preprint and the original research article where this protocol was used:
  1. Chafe, S and Dedhar, S(2022). RNA interference. Bio-protocol Preprint. bio-protocol.org/prep1549.
  2. Chafe, S. C., Vizeacoumar, F. S., Venkateswaran, G., Nemirovsky, O., Awrey, S., Brown, W. S., McDonald, P. C., Carta, F., Metcalfe, A., Karasinska, J. M., Huang, L., Muthuswamy, S. K., Schaeffer, D. F., Renouf, D. J., Supuran, C. T., Vizeacoumar, F. J. and Dedhar, S.(2021). Genome-wide synthetic lethal screen unveils novel CAIX-NFS1/xCT axis as a targetable vulnerability in hypoxic solid tumors . Science Advances 7(35). DOI: 10.1126/sciadv.abj0364

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A
This protocol preprint was submitted via the "Request a Protocol" track.